Is tirzepatide stronger than semaglutide in the Semaglutide vs Tirzepatide trials
Pros Aumento de energa durante el ejercicio, lo que mejora el rendimiento fsico
Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes
Research use via CTN with HREC approval is theoretically available but no Australian trials are registered on ANZCTR for these compounds as of early 2026
Protein is the new star As GLP-1 users are losing fat, they are also battling losing muscle density, so there is a lot of focus on eating protein, Furman said
The results come just a few weeks after a once-weekly injectable GLP-1 drug CT-388 also sourced from Carmot achieved an average weight loss of 18.8% at 24 weeks in a phase 1b trial, which the company said pointed to a potential "best-in-class" profile